Cyclin-dependent protein kinases (Cdks) are key regulatory proteins of the eukaryotic cell cycle. Cdc2 is expressed in late G1/S phase and functions in the G2 to M phase transition. Adenovirus E1A proteins are known to induce the expression of p34 cdc2 and DNA synthesis in normal quiescent cells. In this study, mutational analysis of the human cdc2 promoter revealed that transactivation of the promoter by the E1A proteins in cycling cells is mediated through the two CCAAT box binding motifs. A 110-kDa protein (CBF/cdc2) was identi®ed in nuclear extracts from monkey kidney (CV-1) cells stably expressing E1A as well as from adenovirus-transformed human 293 cells. Further, we show that this E1A-inducible CBF/cdc2 is related to the CBF which was shown to activate the heat shock protein 70 promoter. Analyses of the functional domain(s) of E1A required for the induction of the CBF and transactivation of the cdc2 promoter in these conditions revealed that E1A mutants which were defective in binding the pRB family of proteins or the cellular p300 protein were still active in assays measuring the induction of the CBF and transactivation of the cdc2 promoter, albeit with reduced eciencies. But the E1A mutant which lost both functional domains was inactive in these assays. These results suggest that E1A has redundant functional domains for the induction of the 110-kDa CBF and activation of human cdc2 gene expression.
Introduction
The cyclin-dependent protein kinases (Cdks) are known to be key regulators of cell cycle progression from yeast to humans (Beach et al., 1982; Draetta et al., 1987; Fang and Newport, 1991; Lee and Nurse, 1987; Murray, 1992; Nurse and Bissett, 1981; Reed et al., 1985; Riabowol et al., 1989; Simanis and Nurse, 1986) ; for reviews, see (Draetta, 1990; Murray, 1995; Nurse, 1990; Pines, 1995) . In yeast, a single Cdk, the 34-kDa product of the cdc2 gene in S. pombe or the cdc28 gene in S. cerevisiae regulates both the G1?S and G2?M phase transitions. In higher eukaryotes, distinct Cdks are involved in these steps; p34 cdc2 is primarily required for the G2?M transition (Fang and Newport, 1991; Murray, 1992; Riabowol et al., 1989) and other Cdks (e.g. p33 cdk2
) seem to play a role in the G1?S transition, which leads to DNA replication (Fang and Newport, 1991; Pagano et al., 1993; Tsai et al., 1991) . However there is sucient evidence that p34 cdc2 also plays an important role in phosphorylation of key substrates involved in the G1?S transition (for reviews, see Draetta, 1990; Morgan, 1995; Pines, 1993 Pines, , 1995 and the references therein).
The kinase activity of cdc2 is controlled posttranslationally, and is linked to the growth state of the cells (Simanis and Nurse, 1986 ) (for reviews, see Grana and Reddy, 1995; Morgan, 1995; Pines, 1995) . Moreover, the human cdc2 mRNA and the p34 cdc2 protein decline signi®cantly when cells undergo growth arrest, dierentiation, or development, but increase dramatically as the cells enter the cell cycle (D' Urso et al., 1990; Dalton, 1992; Krek and Nigg, 1989; Lee et al., 1988b; Wang et al., 1991) indicating that p34 cdc2 is required for proliferation. The human cdc2 promoter has consensus binding sites for several transcription factors, which include ATF, cMyb, Sp1, E2F and CCAAT binding factor (Dalton, 1992; Ku et al., 1993) .
DNA tumor viruses such as SV40, adenovirus, and human papillomaviruses (HPV) infect normal cells, which are usually in a quiescent or terminally dierentiated state, and activate the G1?S transition by inducing many of the activities associated with host DNA synthesis and cell cycle progression. Very low levels of p34 cdc2 and endogenous cdc2 mRNA are dramatically reversed by expression of either E1A or SV40-LT, which concomitantly results in the induction of histone H1 kinase activity, pRB phosphorylation, and DNA synthesis in quiescent baby rat kidney (BRK) cells Howe et al., 1990; Wang et al., 1991) . The DNA tumor virus oncogenes accomplish these growth promoting functions by their abilities to associate with a number of host proteins which regulate the cell cycle in normal cells. The best studied targets of these oncoproteins are the tumor suppressor proteins, the retinoblastoma susceptibility gene product (pRB) and p53, which negatively regulate cell proliferation (Buchkovich et al., 1989; DeCaprio et al., 1988; Horowitz et al., 1990; Lee et al., 1988a ; for reviews, see Beck et al., 1998; Cress and Nevins, 1996; Moran, 1993b; Nevins, 1992) .
Analyses of the functional domains of E1A required for these activities revealed that mutants of E1A which were able to bind only one or the other of the cellular p300 or pRB families of proteins still retained the ability to induce endogenous p34 cdc2 expression and kinase activity in quiescent cells (Wang et al., 1991) . However, there is increasing evidence that for cell proliferation, both functional domains of E1A are required (Gopalakrishnan et al., 1997; Wang et al., 1991 Wang et al., , 1993 Wang et al., , 1995 reviewed in (Beck et al., 1998; Moran, 1993a) . Recently, evidence from dierent laboratories has shed light on the role of E1A in cell proliferation. E1A binding to p300/CBP family members, which are transcriptional adaptors for p53-mediated transactivation, induces p53 accumulation, and yet inhibits the ability of p53-dependent activation of p21 Cip1/Waf1 , resulting in release of cells from G1 arrest and in stimulation of cellular DNA synthesis (Avantaggiati et al., 1997; Gu et al., 1997; Lill et al., 1997; Querido et al., 1997; Scolnick et al., 1997; Somasundaram and El Deiry, 1997) . Recently, E1A has also been shown to reverse the transforming growth factor (TGF)-b-mediated growth arrest at G1 phase of the cell cycle by binding the cyclin-dependent kinase inhibitor p27
Kip1 (Mal et al., 1996) . There is considerable experimental evidence for interaction of pRB with E2F-like transcription factors in vitro and in vivo (for reviews, see Cobrinik, 1996; Cress and Nevins, 1996; La Thangue, 1994; Nevins, 1992; Slansky and Farnham, 1996) . The transcriptionally inactive E2F complexes with pRB or pRB-related proteins are disrupted by several viral oncoproteins resulting in transcriptional activation of E2F-dependent genes (Bandara and La Thangue, 1991; Chellappan et al., 1992; DeCaprio et al., 1988; Dyson et al., 1989; Whyte et al., 1988; reviewed in Beck et al., 1998; Cobrinik, 1996; Cress and Nevins, 1996; La Thangue, 1994; Nevins, 1992 and the references therein). In fact, it has shown previously that transactivation of an E2F-dependent adenovirus E2 promoter/CAT reporter is pRB-binding domaindependent in quiescent primary BRK cells (Wang et al., 1995) and in L cells (Raychaudhuri et al., 1991) . Transactivation of a cdc2 promoter/CAT reporter by E1A behaves in a similar manner in quiescent primary BRK cells in requiring the pRB binding domain (E Moran and H-GH Wang, unpublished results) . It is thus likely that in serum-starved or quiescent primary (non-cycling) cells the E2F binding site of the cdc2 promoter plays a role in transactivation by E1A, and that the pRB-binding domain of E1A at least partially mediates this function.
We undertook this study to examine the role of E1A functional domains in transactivation of the human cdc2 promoter in cycling cells under conditions where E2F is expected to be trancriptionally active, and identify other promoter elements that might mediate this activation. The results of this study indicate that the E1A proteins can transactivate the human cdc2 promoter by inducing a 110-kDa CCAAT box binding factor (CBF/cdc2) which speci®cally recognizes the two inverted CCAAT box binding motifs, both of which were required for optimum transactivation. The requirements of the functional domains of E1A for the induction of the CBF were analysed using E1A mutants. The results revealed that the E1A mutants that retained the ability to interact with p300 or the pRB family of proteins were active but the E1A double mutant that lost both interaction properties was inactive.
Previously, a CBF of a similar molecular size has been shown to bind to the CCAAT box motif of the heat shock protein 70 (HSP70) promoter and activate the transcription from the HSP70 promoter/reporter constructs (CBF/HSP70) and the isolation of its cDNA was reported (Lum et al., 1990) . The results of our study show that the E1A-inducible CBF that transactivates the cdc2 promoter/reporter constructs is related to the CBF/HSP70 based on the following evidence. First, E1A activates the transcription of the endogenous CBF/HSP70 gene. Second, the CBF/cdc2 induced by E1A also binds to the CCAAT motif of the HSP70 promoter. Third, the CBF/HSP70 activates transcription from the human cdc2 promoter/reporter construct in a CCAAT box motif-dependent manner.
Results
Transactivation of human cdc2 promoter in cycling cells is mediated through the CCAAT box motifs Adenovirus E1A proteins transactivate the human cdc2 promoter through the CCAAT box-binding motifs. Adenovirus E1A proteins are known to activate transcription of viral and cellular proteins. Of the two E1A proteins, the E1A.289R is primarily responsible for transactivation of viral early genes and the 46 amino acid residues in the conserved region (CR3) unique to this E1A protein are required for this function. The E1A.243R also exhibits transactivation properties under certain experimental conditions (for a review, see Shenk and Flint, 1991) . We examined whether the E1A oncoproteins target the human cdc2 promoter through their growth regulatory properties or through their distinct functions involved in transactivation of viral and cellular promoters. The regulatory elements of the human cdc2 promoter, previously identi®ed by sequence analysis (Dalton, 1992; Ku et al., 1993) are shown in Figure 1 .
Monkey kidney (CV-1) cells were transfected with a series of reporter plasmids containing deletions of the cdc2-promoter linked to the reporter gene CAT ( Figure  1 ) either in the absence or presence of the E1A expression plasmids, pRC-CMV13S (E1A.289R) or pRC-CMV12S (E1A.243R). CAT activities were determined in extracts prepared 45 h post-transfection. Transfection experiments were carried out in duplicates and each experiment was repeated at least once.
As shown in Figure 2 and Table 1 , transient expression of E1A.289R or E1A.243R in CV-1 cells eciently induced transcription from the parent cdc2- Figure 1 Schematic representation of the human cdc2 promoter/ CAT expression plasmid. The relative positions of the cis-acting regulatory elements are indicated. Plasmids were constructed by standard recombinant DNA cloning techniques as described under Materials and methods
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A Tanimoto et al PstI plasmid (6.6-fold by E1A.289R and 5.2-fold by E1A.243R) as well as from the cdc2-TaqI promoter construct (4.1-fold for E1A.289R and 3.1-fold for E1A.243R). The result that both E1A proteins were ecient in transactivation of the human cdc2 promoter suggests that conserved region 3 (CR3) of the E1A.289R did not contribute to any signi®cant extent in the activation of this cellular promoter. Previous studies have demonstrated the transcription inducing activity of the E1A.12S gene product but the eciency of this activity depended on the target gene. In the activation of the cellular HSP70 promoter, the activity of the E1A.13S was only slightly higher than that of the E1A.12S (12-fold versus ninefold compared with E1A-de®cient mutant; Simon et al., 1987; reviewed in Shenk and Flint, 1991) . Moreover, the E1A.289R used in this study was also able to transactivate the adenovirus E2-early promoter about sixfold in a dose-dependent manner (data not shown).
Further deletion of sequences upstream of the SmaI site (7109) as in the cdc2-SmaI plasmid did not reduce the level of transactivation signi®cantly (5.4-fold by E1A.289R and 3.2-fold by E1A.243R) suggesting that in cycling CV-1 cells, where E2F is already active, the E1A proteins mediate a further transactivation function through the two inverted CCAAT box-binding motifs within this promoter element. In order to test this possibility, we used two promoter constructs for transient expression and CAT assays either in the absence or presence of one of the E1A expression plasmids (E1A.289R or E1A.243R) and measured the CAT activities. One of the promoter constructs is the cdc2-TaqMutCCAAT plasmid in which both CCAAT box motifs were mutated from ATTGG to AGGCC and the other is the cdc2-Taq SA in which the region between SmaI at position 7109 and ApaI at position 728 nucleotides upstream of the transcription start site which includes the two CCAAT motifs were deleted. As shown in Figure 2 and Table 1 , E1A-mediated transactivation was nearly abolished in both promoter constructs. These results further demonstrate that the two CCAAT box motifs of the cdc2 promoter play an important role for transactivation by E1A proteins in cycling CV-1 cells. Interestingly, either the cdc2-TaqMutCCAAT or the cdc2-Taq SA construct still contains consensus binding sites for ATF, c-myb, Sp1 and E2F transcription factors, suggesting that these sites do not play any signi®cant role in E1A-mediated transactivation of the cdc2 promoter in cycling cells. The results of Figure 2 and Table 1 also show that substitution mutation of the two inverted CCAAT box motifs fortuitously increased the basal activity of the cdc2 promoter, suggesting a possibility that wild type CCAAT box motifs mediated transcriptional repression rather than activation in cycling cells in the absence of E1A although this increase in basal activity was not observed with the deletion mutant (cdc2-Taq SA). These experiments in Figure 2 were repeated three times and the results are reproducible. cdc2 promoter activity requires both CCAAT box motifs Next we sought to determine whether transactivation of the cdc2 promoter by E1A proteins requires both CCAAT box motifs or whether a single site would be sucient. We constructed two CCAAT-box binding site mutants in the cdc2-TaqI backbone in which only one site (proximal or distal) was mutated (see Figure  1) . CV-1 cells were transfected with either the wild type cdc2-TaqI or one of the mutant plasmids alone, or cotransfected with the pRC-CMV13S (E1A.289R) expression plasmid. The CAT activities of extracts prepared from transfected cells were determined. The cdc2-Taq/ggcctCCAAT plasmid (containing a mutant distal CCAAT motif) had 14% of the basal activity, whereas the cdc2-Taq/CCAATggcct (containing a mutant proximal CCAAT box motif) had only 2% of the basal activity obtained with the cdc2-TaqI plasmid. The results shown in Figure 3 (a and b) indicate that both CCAAT box motifs were required for optimum basal activity although the proximal motif plays a more important role to the basal activity than the distal motif. However, the degree of transactivation by the E1A protein was approximately same with either one of the CCAAT box motifs kept as wild type (Figure 3b ). The results in Figure 2 were quantitated by liquid scintillation counting of the radioactivity in each sample. The relative basal activities of cdc2 promoter/reporter constructs are given with respect to the value of cdc-2-TaqI construct chosen arbitrarily as 100%. Each promoter/reporter construct was cotransfected with either empty vector as control (pCMVex), or with E1A expression plasmid (12S.WT or 13S.WT), and the CAT activities from transfected cells were assayed. The degree of transactivation by the E1A proteins is presented as fold activation calculated as ratios of CAT activities obtained from 12S.WT or 13S.WT-cotransfected cells over those obtained from empty vector-cotransfected cells. These experiments were repeated three times Figure 2 Transactivation of various mutants of cdc2 promoter by adenovirus E1A proteins. CV-1 cells were cotransfected with 3 mg of a cdc2 promoter/CAT plasmid and 0.1 mg of pRC-CMV13S (encoding E1A.289R) or pRC-CMV12S (encoding E1A.243R) plasmid using the liposome-mediated DNA transfection method. In the absence of an E1A expression plasmid, an equal amount of pCMV vector plasmid was used to equalize the total amount of plasmid DNA in each transfection. Extracts were prepared 45 h after transfection and the CAT activity was determined at 378C for 1 h. (a) represents autoradiography of a thin-layer chromatography plate from a representative CAT assay
Characterization of CCAAT box binding factor (CBF/ cdc2) induced by E1A proteins
The results presented thus far indicate that E1A proteins transactivate the cdc2 promoter and that either of the two CCAAT box motifs of the promoter is sucient for this transactivation. Next, we sought to investigate whether E1A protein mediates this transactivation by inducing a transcription factor which speci®cally recognized the CCAAT motifs of the cdc2 promoter. To address this question, we prepared stably transfected CV-1 cells expressing either the E1A.289R or the E1A.243R using the neomycin resistance marker and G418 selection as described under Materials and methods. Nuclear and cytoplasmic extracts from stably transfected CV-1 cells, or nuclear extracts from COS-7 and the human 293 cells were fractionated by SDS ± PAGE and analysed by Southwestern blotting. The results shown in Figure 4a , indicate that a 110-kDa protein from the nuclear fraction was detectable only at low levels in mock-transfected CV-1 cells, but was induced in cells expressing either of the two E1A proteins. This protein was also present at signi®cant levels in human 293 cells ( Figure 1 ). CV-1 cells were cotransfected with 3 mg of wild type or mutant cdc2 promoter/CAT plasmid (cdc2-TaqI, cdc2-Taq/ ggcctCCAAT, or cdc2-TaqCCAATggcct), and 0.1 mg of pRC-CMV13S (E1A.289R) plasmid. The CAT activity was determined at 378C for 2 h. (a and b) represent the autoradiography and the bar graph, respectively. For each set of samples with dierent promoter/reporter constructs, the degree of transactivation by the E1A proteins was estimated by normalizing the empty vector (pCMVex) control values to 1 Figure 4 Southwestern blotting analyses of CCAAT box binding proteins from cells stably expressing E1A proteins. CV-1 cells were stably transfected with either the pRC-CMV13S (E1A.289R) plasmid or the pRC-CMV12S (E1A.243R) and the cells expressing the respective E1A protein were selected by resistance to G418 as described (Kingston, 1991) . Cytoplasmic (C) and nuclear (N) extracts were prepared and Southwestern analyses were performed as described in Materials and methods. (a) proteins were separated on a 8% SDS ± PAGE. Lanes 1 and 4, mock-transfected CV-1 cells; lanes 2 and 5, CV-1 cells stablytransfected with pRC-CMV12S; lanes 3 and 6, CV-1 cells stablytransfected with pRC-CMV13S; lane 7, nuclear extract from human 293 cells. In each lane, 120 mg of total proteins were loaded. (b) Southwestern blot analyses of nuclear extracts from CV-1 cells (lane 1 as control), COS cells (lane 2) and 293 cells (lane 3) are shown. Speci®city of binding of the 110-kDa CBF to the cdc2 CCAAT box motif was independently con®rmed by a DNA-anity pull-down assay. The nuclear extracts were incubated with biotin labeled CCAAT box motif of the cdc2. After binding, reaction mixtures were incubated with streptavidinagarose beads and subjected to centrifugation. For competition experiments, the nuclear extracts were ®rst incubated with 10-fold excess of unlabeled oligonucleotide before incubation with biotinylated oligonucleotides, keeping the rest of the steps same. The proteins pulled down by streptavidin-agarose were analysed by SDS ± PAGE and Southwestern blotting. Lane 4: no competitor; lane 5:+competitor 110-kDa CBF/cdc2 was induced by SV40-LT in COS cells (Chen et al., 1996) and by E1A proteins in stably transfected CV-1 cells or in transformed human 293 cells, and it speci®cally bound the CCAAT box motif of the human cdc2 promoter.
The results presented in Figure 3 indicate that both CCAAT box motifs of the cdc2 promoter were required for optimal basal activity although either motif was sucient for E1A-inducibility. We sought to determine whether both motifs were also required to form speci®c DNA-protein complexes. For this experiment, we used nuclear extracts from human 293 cells as the source of the 110-kDa CBF/cdc2 protein. Electrophoretic mobility shift assays (EMSA) were performed using the labeled 180-bp fragment as the DNA probe, which contained either the two wild type CCAAT-box motifs or one of the motifs (distal or proximal) in the mutant form. The results of EMSA shown in Figure 5a and b indicate that the nuclear extracts from 293 cells formed speci®c DNA-protein complexes with the wild type CCAAT box motifs but not when both motifs were mutated (compare lanes 2 and 3). Speci®c DNA-protein complexes were also formed when only one of the motifs was mutated (see lanes 4 and 5).
The speci®city of this binding of the CBF/cdc2 present in human 293 cells to the CCAAT box motifs of the cdc2 promoter was further established by competition experiments (Figure 5c ). The wild type 180-bp DNA fragment containing the two CCAAT box motifs of the cdc2 promoter was used as the probe, and the distal CCAAT box motif of the tk promoter (lanes 2 ± 5) or an unrelated oligonucleotide containing the E2F-binding site of the adenovirus E2A promoter (Wu et al., 1995) were used as competitors in increasing amounts (506 ± 1006). As shown in Figure  5c , the related CCAAT box binding motif of the tk promoter was able to compete with the binding of the nuclear protein with the labeled CCAAT box motifs of the cdc2 promoter, but not the unrelated E2F-binding site oligonucleotide. Lanes 1 and 9 represent controls for EMSA in which the wild type and mutant cdc2 DNA probe, respectively, were added without nuclear extract. Lane 10 represents another control in which the nuclear extract was added to the mutant cdc2 DNA probe.
Functional domains of E1A required for the induction of the 110-kDa CBF
The E1A proteins are known to have at least two independent domains involved in binding to cellular proteins and mediating induction of the cell cycle and proliferation. One of these domains is located in conserved region 2 and is involved in binding the pRB and pRB-related proteins, p107 and p130. The second domain is located at the N-terminus and is involved in binding the p300 protein. Although either domain is independently active in cellular DNA synthesis and p34 cdc2 expression, both protein binding domains are required in the same E1A molecule for immortalization function (Wang et al., 1993 (Wang et al., , 1995 . We examined the role of the functional domains of E1A in mediating the induction of the 110-kDa CBF in cycling cells. Previous studies on the role of E1A functional domains in inducing p34 cdc2 were done in quiescent primary rodent cells (Wang et al., 1991) . In our study, we chose cycling rat liver epithelial (RLE) cells with relatively low passage history (passage 13) for cdc2 promoter-CAT transient transactivation assays and EMSA using E1A mutants. We found that the basal level of the CBF/cdc2 in mock-infected RLE cells was essentially undetectable under our assay conditions ( Figure 6 ) and that E1A 12S.WT induced this protein signi®cantly higher in RLE cells than in CV-1 cells (data not shown).
Nuclear extracts from cells infected with either the wild type or the E1A mutants containing an inactive single binding domain were analysed by EMSA. The results shown in Figure 6a indicate that the wild type and the single domain mutants, which retain the ability to interact with either p300 or the pRB family proteins, were still active in inducing the formation of a major Figure 5 DNA-binding activity of nuclear extracts from human 293 cells to wild type and individually mutated CCAAT box motifs of cdc2 promoter. Nuclear extracts from 293 cells were prepared and EMSA was carried out using a 180-bp cdc2 promoter fragments as the probe and 10 mg of nuclear extract as described in Materials and methods. (a and b) represent the autoradiography and quantitation using a PhosphorImager respectively. Lane 1, probe alone; lanes 2 ± 5, nuclear extracts from human 293 cells were added. Lanes 2 and 3, both inverted CCAAT box motifs were either of wild type or mutant, respectively; lanes 4 and 5, the distal motif as mutant and the proximal motif as wild type or vice versa, respectively. (c) The speci®city of binding of nuclear proteins to the two CCAAT box motifs of cdc2 promoter was examined by EMSA. The wild type 180-bp DNA fragments containing the two CCAAT box motifs and the nuclear extracts from human 293 cells were used in the presence or absence of a related CCAAT box motif of the tk promoter or an unrelated E2F binding motif of the adenovirus E2A promoter in competition experiments. Lane 1, wild type DNA probe only; lane 2, no competitor; lanes 3 ± 5, 506, 1006and 2006of distal CCAAT box motif of the tk promoter; lanes 6 ± 8, 506, 1006 and 2006 of the E2F binding site of adenovirus E2 early promoter (Wu et al., 1995) . Lanes 9 and 10 represent controls in which mutant cdc2 probe was incubated in the absence or presence of nuclear extracts, respectively DNA-protein complex (shown by arrow; see lanes 5 ± 9). In 12S.RG2 (lane 6), an Arg?Gly substitution at position 2 of E1A abolished its ability to bind p300. In 12S.YH47/928 (lane 7), a Tyr?His substitution at residue 47 plus a Cys?Gly substitution at residue 124 abolished the E1A's ability to interact with pRB, p107, and p130 but leave p300 binding unimpaired (Wang et al., 1995) . The E1A mutant 12S.NCdl has a deletion of the region between 86 and 120 amino acid residues (Zerler et al., 1987) . This mutant binds both the pRBrelated proteins and p300 but diers from wild type E1A.12S in that both sets of cellular proteins are not readily detected in the same complex (Wang et al., 1995) . By UV cross-linking analyses, we established that the complex shown by the arrow contains the 110-kDa CBF (data not shown). The faster-migrating DNA-protein complexes may contain other CBF-DNA complexes and were not studied further. Nuclear extracts from 293 cells (lane 2), uninfected RLE cells (lane 3), and RLE cells infected with wild type adenovirus-2 (expressing both E1A.12S and E1A.13S products) (lane 4) or the adenovirus encoding the wild type E1A.12S (lane 5) were used as controls. The speci®city of the DNA-protein complexes were veri®ed by using 1006excess of unlabeled cdc2 CCAAT box motif as a competitor (lanes 10 ± 17).
Next we examined the E1A double mutant (d101/08/ 520) in which both the N-terminal p300-binding domain and the pRB binding domain were inactivated for its ability to induce the 110-kDa CBF. The results of EMSA shown in Figure  6b indicate that the double mutant lost the ability to induce the 110-kDa CBF. These results taken together indicated that either the p300-or pRB-binding domain alone was sucient for the induction of the 110-kDa CBF but when both domains were mutated E1A was inactive in this function.
To examine further whether there is a correlation between the induction of the CBF/cdc2 and transactivation of the promoter containing the CCAAT box motifs, we used the basal promoter/reporter plasmid, pTI-CAT (Shi et al., 1991) or the pTI-CAT into which the two inverted CCAAT box motifs of the cdc2 promoter were cloned upstream from the transcription start site, pTI-CCAAT-CAT, as described previously (Chen et al., 1996) . RLE cells were infected with adenovirus 12S.WT encoding the wild type E1A.243R Figure 6 Analysis of the activity of the E1A mutants in induction of the 110-kDa CBF. EMSA using nuclear extracts of infected RLE (50 plaque forming units/cell) or uninfected cells and the labeled CCAAT/cdc2 motif as the probe were carried out as described under Materials and methods. Arrows indicate the positions of the DNA-protein complexes. (a) Lane 1: free probe; lane 2: 293 cell extract as positive control; lane 3: extract from uninfected RLE cells; lane 4: extract from wild type adenovirus type 5 infected cells; lanes 5 ± 9: extracts from RLE cells infected with adenoviruses 12S.WT, 12S.RG2, 12S.YH47/928, a mixture of 12S.RG2 +12S.YH/47/928 and 12S.NCdl, respectively. Lanes 10 ± 17: homologous competitor of unlabeled cdc2 motif (1006) was included in the extracts used in lanes 2 ± 9. (b) Extracts derived from infected RLE cells were as follows. Lane 1: 12S.WT, lane 2: double mutant d101/08/520; lane 3: 12S.NCdl; lanes 4 ± 6: unlabeled cdc2 motif used as a competitor as described in a Figure 7 Transactivation of a basal promoter/CAT reporter containing the two inverted CCAAT box binding sites by wild type and mutant E1A. (a) Transient transactivation assays were performed by infecting RLE cells with adenovirus E1A.12S WT or mutant (25 plaque forming units/cell) as described under Materials and methods section. After infection for 2 h, cells were transfected with either pTI-CAT (basal promoter/reporter which contains only the TATA element upstream of the CAT reporter gene) (Shi et al., 1991) or pTI-CCAAT-CAT in which the two inverted CCAAT box motifs of the cdc2 promoter were cloned into the basal promoter as described (Chen et al., 1996) . Cell lysates were prepared and CAT assays were carried out as described under Materials and methods. The CAT assays of two independent experiments are shown. (b) The radioactivity of acetylated chloramphenicol from each experiment was determined by scintillation counting, and the average values of each set were calculated. The pTI-CAT containing only the TATA element displayed low promoter activity as reported (Shi et al., 1991) , and this value was taken arbitrarily as 1 for plotting fold activation in the absence and presence of ectopic expression of wild type (WT) and mutant E1A proteins introduced through virus infections as bar graphs
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A Tanimoto et al or its mutants described above. Infected cells were transfected with the pTI-CAT (basal promoter) or pTI-CCAAT-CAT, and the cell lysates were used for CAT assays. The results shown in Figure 7 indicated that the basal CAT activity expressed from the pTI-CAT was very low (Figure 7a , lanes 1 and 2) as reported previously (Shi et al., 1991; Chen et al., 1996) . The two CCAAT box motifs cloned upstream of the transcription start site activated this basal promoter activity 18-fold (Figure 7a , lanes 3 and 4) consistent with our previous report (Chen et al., 1996) . Interestingly, expression of the E1A.12S.WT transactivated the pTI-CCAAT-CAT 250-fold over the level achieved with the basal promoter, pTI-CAT (lanes 5 ± 8). The single binding domain mutant E1As, 12S.YH47/928 and 12S.RG2, which are defective in binding the pRB families of proteins and p300, respectively, also transactivated the pTI-CCAAT-CAT promoter 116 ± 128-fold over the level of the pTI-CAT (lanes 9 ± 16). However, the double mutant defective in both pRBand p300-binding activities was practically inactive in this assay (lanes 17 ± 20). Thus the results shown in Figures 6 and 7 , taken together, suggest that the CCAAT box motifs play an important role in the transactivation of the cdc2 promoter by adenovirus E1A. Furthermore, either of the functional domains of E1A, that which binds either the pRB family of proteins or that which binds p300, is sucient for transactivation of the cdc2 promoter via the inverted CCAAT box motifs. Activation in either case is mediated by induction of the CBF/cdc2, although at about 50% of the level achieved with the wild type E1A.12S.243R.
CBF/cdc2 induced by E1A is related to the CBF that activates the HSP70 promoter
There are several CCAAT box binding proteins reported in the literature that speci®cally recognize the promoters of diverse genes: CP1 and CP2 (Chodosh et al., 1988) , CBP (Graves et al., 1986) , the 114-kDa CBF that activates the HSP70 promoter (Lum et al., 1992) , a distinct set of nuclear factors of the NF1/CTF family which recognize the adenovirus 2/5 origin of DNA replication (Jones et al., 1987; Santoro et al., 1988) , and C/EBP, which recognizes the CCAAT box motif present in the SV40 enhancer core sequence (Landschulz et al., 1988) . We sought to determine whether the CBF/cdc2 induced by SV40-LT (Chen et al., 1996) and E1A (this study) is related to the previously characterized 114-kDa CBF that activates the HSP70 promoter (CBF/ HSP70; Lum et al., 1990) . We carried out three lines of experimental approaches to address this question. First, we examined whether E1A.12S could activate transcription of the endogenous CBF/HSP70 gene. RLE cells were infected with adenovirus E1A.12S and the total RNA from infected and uninfected cells were subjected to Northern blot analyses using the cDNA encoding the CBF/HSP70 as a probe. The results shown in Figure 8 indicate that endogenous level of CBF/HSP70 mRNA is very low in uninfected cells (lane 1), whereas there is a signi®cant increase in the level of this mRNA in cells expressing E1A.12S (lane 2).
Second, we examined using EMSA whether the CBF/ cdc2 in human 293 and HeLa cells could also recognize the CCAAT box motif of the HSP70 promoter. The results shown in Figure 9a indicate that the CBF present in human 293 and HeLa cells could recognize the CCAAT motif of the cdc2 or HSP70 promoter (lanes 1 ± 4), and that each of the motifs could compete with the other for binding of the CBF in cross competition experiments (lanes 5 ± 12). These results were con®rmed by Southwestern blot analyses (Figure 9b ) which shows that both CCAAT motifs of cdc2 and hsp70 promoters could bind to the 110-kDa CBF.
Third, we further investigated whether the ectopic expression of CBF/HSP70 could transactivate the cdc2 promoter/reporter expression. HeLa cells were transfected with cdc2-SmaI promoter/reporter construct either in the presence or absence of CBF/HSP70 expression plasmid, and the lysates from transfected cells were assayed for CAT activity (Figure 9c ). There was a 30-fold activation of CAT reporter expression from the cdc2-SmaI promoter/reporter plasmid compared with the basic promoter/CAT vector control indicating that the two CCAAT box motifs of the cdc2 promoter were transcriptionally active in HeLa cells. Cotransfection of CBF/HSP70 expression plasmid and the cdc2-SmaI reporter plasmid stimulated the reporter expression twofold relative to the level achieved with the cdc2-SmaI promoter/reporter alone (Figure 9c ). This observation was further con®rmed by additional experiments which revealed that the two CCAAT motifs of the cdc2 promoter activated CAT reporter expression from the basic promoter ®vefold (pTI-CAT versus pTI-CCAAT-CAT) in HeLa cells which was further stimulated twofold in the presence of CBF/ HSP70 expression (data not shown). These results taken together suggest that the CBF which is induced by viral oncoproteins and is involved in activation of the cdc2 promoter is similar or related to the CBF/ HSP70.
Discussion
The oncoproteins of small DNA tumor viruses are able to disrupt the normal cell growth control that leads to Figure 8 Transcriptional activation of endogenous CBF/HSP70 gene by E1A. RLE cells were mock-infected (7) or infected (+) with adenovirus E1A.12S. Total RNA was extracted and subjected to Northern blot hybridization as described under Materials and methods. Autoradiography (upper panel) and methylene blue-stained gel (bottom panel) are shown uncontrolled cell proliferation by their abilities to associate with a number of cellular growth regulatory proteins through multiple domains. The E1A proteins alter the cell growth regulation through at least two independent protein binding domains. The N-terminal domain binds the cellular protein p300 and mutations in this region that aect binding also correlate with impairment of immortalization function of E1A. The conserved region 2 of E1A binds pRB and pRB-related p107 and p130 and dissociates transcriptionally inactive E2F-pRB or -pRB-related protein complexes such that free E2F can activate a number of cell cycle regulatory genes involved in G1 to S phase transition including p34 cdc2 expression and DNA synthesis (reviewed in Beck et al., 1998 and the references therein).
The functional domains of E1A involved in immortalization, cellular DNA synthesis and p34 cdc2 expression have been extensively studied by mutational analyses by several laboratories (Howe et al., 1990; Quinlan, 1994; Subramanian et al., 1988; Wang et al., 1991 Wang et al., , 1993 Wang et al., , 1995 reviewed in Beck et al., 1998 and the references therein). A single and a double mutant in region 2 (e.g. 12S.928 and 12S.YH47/928, respectively; see Wang et al., 1993) are ecient in induction of DNA synthesis and/or p34 cdc2 expression although either one is incapable of binding pRB to a detectable extent. Similarly, the N-terminal point mutant (e.g. 12S.RG2 used in this study), defective in binding p300 but capable of binding pRB, p107 and p130, also retained the ability to induce ecient DNA synthesis and p34 cdc2 expression at or near wild type levels (Wang et al., 1991 (Wang et al., , 1993 . However, inactivation of both protein binding domains abolished the induction of both activities. Moreover, the immortalization function of E1A correlated with its ability to bind both p300 and pRB family proteins in the same multimeric complex of E1A (Wang et al., 1995 ; for a review, see Beck et al., 1998) .
Since human cdc2 gene expression is correlated with cell growth, it is likely to be regulated negatively by pRB and p53, and positively by the cellular and viral oncogene products. The human cdc2 promoter has multiple regulatory elements (Dalton, 1992; Ku et al., 1993) . Previous studies indicated that the region containing the E2F, Sp1 and CCAAT box binding sites of the cdc2 promoter is important for the basal activity of the promoter (Chen et al., 1996) . pRB negatively regulates the cdc2 promoter, and the two E2F binding sites, a high anity (7125) and a low anity (7107) sites, of the cdc2 promoter were required for optimal repression (Dalton, 1992) .
The transactivation of a cdc2 promoter/CAT reporter by E1A in quiescent primary BRK cells also requires the pRB binding domain (E Moran and H-GH Wang, unpublished results). These results suggest that in serum-starved or quiescent primary cells the E2F binding sites of the cdc2 promoter may at least in part play a role in transactivation by E1A, and that the pRB-binding domain of E1A is involved in this function.
However, in a genomic DNA foot-printing study, the high anity E2F site of the cdc2 promoter was shown to be unoccupied in vivo in serum-starved human ®broblasts and after stimulation by the addition of serum (Tommasi and Pfeifer, 1995) . In contrast, it was shown that the 720 element, which diers from the known E2F consensus binding site by one nucleotide, was involved in speci®c interaction with E2F-4/p130 complex present in G0 cells which disappeared as cells entered S phase. Thus, the function of the 720 element seems to be to recruit the E2F-4/p130 complex as a repressor of cdc2 gene expression in G0 and G1 cells (Tommasi and Pfeifer, 1995) . The requirement for pRB-binding domain of E1A for activation of cdc2 gene expression in cycling cells identi®ed in this study may be to release from repression by the 720 element. Interestingly, mutations within the 720 element also caused an increase in basal activity of the cdc2 promoter in quiescent cells as well as in cycling cells although to a lesser extent in the latter, supporting a conclusion that a 720 element- (Chen et al., 1996) either alone or in the presence of 2.5 mg of the CBF/HSP70 expression plasmid (Lum et al., 1990) using the liposome-mediated DNA transfection method. DNA amounts were equalized by the addition of vector plasmid. Extracts were prepared and CAT assays were performed as described under Figure 2 mediated repression in G1 phase is relieved by these mutations (Tommasi and Pfeifer, 1995) . In this study, our observation that the basal activity of the cdc2 TaqMutCCAAT promoter/reporter is increased in cycling cells suggests that the wild type CCAAT motifs may mediate transcriptional repression. It is then conceivable that E1A may stimulate cdc2 gene expression by abrogating this repression.
Our analyses of the functional domains of E1A required for transactivation of the human cdc2 promoter in cycling cells indicated that abrogation of either p300 binding or pRB binding activity of E1A did not signi®cantly aect the ability of E1A to induce the 110-kDa CBF/cdc2. However, when both functional domains were mutated, E1A was essentially inactive in this function. The independent abilities of the two protein binding domains of E1A to induce the CBF/ cdc2 in cycling cells closely resembles their abilities to induce p34 cdc2 expression and cellular DNA synthesis during G1 to S phase transition.
There are at least two possible mechanisms for the induction of the CBF/cdc2 by E1A. First, E1A activates the transcription of the endogenous CBF/ cdc2 gene. Second, E1A enhances the anity of the CBF/cdc2 for binding the CCAAT motifs of the cdc2 promoter indirectly such as by phosphorylation modi®cation. In order to test the second possibility, nuclear extracts from human 293 cells were treated with increasing amounts of calf intestinal alkaline phosphatase and were subjected to Southwestern blot analyses. The results indicated that the DNA binding anities were not aected by this phosphatase treatment (data not shown).
E1A has also been shown to interact with the Cdk inhibitor p27
Kip1 and reverse its inhibitory eect on the activity of the cyclin-cdk2 kinase complex (Mal et al., 1996) . The possibility that the double mutant dl01/08 (deletion of residues 4 ± 25 and 124 ± 127; (Howe et al., 1990) ) used in this study is defective in binding to p27
Kip1 and thus resulting in loss of induction of the CBF/cdc2 can not be ruled out. In this regard, it is worth noting that the same deletion mutations in either of the two domains were independently pro®cient in inducing cellular DNA synthesis (the domain 2 and the N-terminal mutants, either same as the wild type or at 60 ± 70% of the wild type levels, respectively). Moreover, even complete deletion of domain 2 (residues 121 ± 150 as in 12S.Cxdl) was still as active in inducing DNA synthesis and p34 cdc2 levels as the N-terminal deletion mutant 12S.2-36 albeit at a lower level than the 12S.WT (Wang et al., 1991) . Further work is necessary to de®ne precisely the functional domains of E1A involved in physical interaction with the p27 Kip1 using point mutants and analyse their contribution, if any, to the induction of the 110-kDa CBF/cdc2 and p34 cdc2 expression. The results of this study also suggests that the E1A-inducible CBF that activates the human cdc2 promoter through the two CCAAT motifs may be related to a 114-kDa CCAAT box binding factor that regulates HSP70 gene expression (CBF/HSP70) (Lum et al., 1990) . Our data shows that E1A.12S stimulates the transcription of the endogenous CBF/HSP70 gene. It is further supported by the results that CBF/cdc2 from human 293 cells binds equally well to CCAAT box motifs of cdc2 and HSP70 promoter in EMSA.
Moreover, the CBF/HSP70 activates the cdc2 promoter/reporter in transient transfection asssays in a CCAAT box-dependent manner. Our results indicate that although the human cdc2 promoter can be transactivated by E1A by induction of the 110-kDa CBF/cdc2 in cycling CV-1 and RLE cells (Figures 2 ± 4 , 6 and 7), transactivation of the human cdc2 promoter by ectopic expression of the CBF/HSP70 was dependent on the cell type; CV-1 cells were inert (Chen et al., 1996) in comparison with HeLa cells (Figure 9 ). These results are consistent with the observation that HSP70 promoter/reporter was also activated dierentially by the CBF/HSP70 in Chinese hamster overy cells and SV40-LT-transformed monkey kidney (COS) cells (Lum et al., 1992) . Puri®cation of the CBF/cdc2 from human 293 cells, followed by cloning of the cDNA for the CBF/cdc2 will resolve whether these two proteins are related.
The E1A-inducible CBF/cdc2 appears to be distinct from the heterotrimeric CBF/NF-Y (also known as CP1) (Chodosh et al., 1988; Dorn et al., 1987; Maity et al., 1988; van Huijsduijnen et al., 1990) . NF-Y requires all three subunits for DNA binding (Maity et al., 1992) , whereas the CBF/cdc2 appears to be a single polypeptide of 110 ± 114-kDa which binds to CCAAT motifs of cdc2 and HSP70 promoters. NF-Y also binds to the CCAAT box motifs of the tk promoter (Chang and Liu, 1994; Good et al., 1995; Pang and Chen, 1993) . Recently, a heterotrimeric NF-Y/115-kDa CCAAT box binding protein (CBP/cyc A) complex was shown to bind the CCAAT box motif of the cyclin A promoter (Kramer et al., 1997) . Further studies are required to determine whether this 115-kDa CBP/cyc A is related to the E1A-inducible CBF/cdc2 characterized in this study.
Materials and methods

Plasmids
Methods to construct recombinant plasmids were carried out according to standard procedures (Sambrook et al., 1989) . The cdc2-PstI plasmid was kindly provided by Dr Bruno Calabretta and its construction has been described (Ku et al., 1993) . The derivatives of the cdc2 promoter plasmids, cdc2-TaqI, cdc2-Taq SA, cdc2-TaqMutCCAAT and the cdc2-SmaI were described (Chen et al., 1996) . The cdc2-Taq/CCAATggcct plasmid was constructed by replacing the proximal wild type CCAAT box motif of the cdc2-TaqI with the mutated motif excised from the double mutant cdc2-TaqMutCCAAT plasmid using the two AccI sites. In the same way, the plasmid cdc2-Taq/ ggcctCCAAT, containing the mutant distal CCAAT motif, was constructed by replacing the proximal motif of the double mutant (cdc2-TaqMutCCAAT) plasmid with the wild type motif from the cdc2-TaqI (Figure 1) . The plasmids pRC-CMV13S and pRC-CMV12S (encoding E1A.289R and E1A.243R, respectively) were kindly provided by Dr Chinnadurai (Boyd et al., 1993) .
Adenoviruses
Adenoviruses expressing wild type E1A.243R and the mutants (12S.WT, 12S.RG2, 12S.YH47/928, 12S.NCdl) have been described previously (Wang et al., 1991) . The double mutant dl01/08/520 was kindly provided by Dr Stanley Bayley . All viruses were propagated and titered on monolayers of 293 cells. For preparation of nuclear extracts, RLE cells were infected at 25 to 50 p.f.u./cell. Cells were harvested 28 h postinfection and nuclear extracts were prepared for EMSA as described below.
Cell culture, DNA transfections and CAT activity assays Monkey kidney CV-1, COS-7 (constitutively expressing SV40-LT) cells and human 293 cells (constitutively expressing both E1A and E1B proteins; Graham et al., 1977) were cultured at 378C, 5% CO 2 in Dulbecco's Modi®ed Eagle Medium containing 50 mg/ml each of streptomycin and penicillin and 10% de®ned/supplemented bovine calf serum (Hyclone). Fisher rat liver epithelial cells (RLE) obtained from Dr Snorri Thorgeirsson (Huggett et al., 1991) , were cultured in DMEM/F12 (1 : 1) supplemented with 10% FBS.
All plasmids were puri®ed by CsCl-ethidium bromide equilibrium density gradients (Sambrook et al., 1989) . For transfections, cells were grown up to 50 ± 70% con¯uence in 25-cm 2 culture¯asks (Corning) and the plasmid DNAs were transfected as described previously (Chen et al., 1996) , except that cationic lipid mixture was made from dioleoyl-L-aphosphatidyl ethanolamine and dimethyldioctadecyl ammonium bromide as described (Rose et al., 1991) . A suspension of 30 ml of lipid mixture and 3 mg of a cdc2 promoter-CAT reporter plasmid were used for each monolayer of cells in a 25-cm 2¯a sk. In the experiments in which E1A expression plasmids were used, 0.1 mg of the plasmids encoding E1A.289R or E1A.243R protein was also mixed with the cdc2 promoter-CAT reporter plasmid prior to the addition of cationic lipids. Conditions for transfections were as described (Chen et al., 1996) . Cells were harvested 45 h posttransfection, and cell extracts were prepared by three cycles of freeze-thawing. For analyses of functional domains of E1A involved in induction of the CBF/cdc2, RLE cells in 25 cm 2 asks were infected with adenovirus E1A.12S (243R) wild type or mutants (25 ± 50 p.f.u./cell) for 2 h. Subsequently cells were transfected for 6 h in the absence of serum and in the presence of cationic lipids as described above mixed with 3 mg of pTI-CAT (basal promoter; see Shi et al., 1991) or pTI-CCAAT-CAT plasmid (in which the two inverted CCAAT box motifs of the human cdc2 promoter were cloned upstream of the transcription start site in the basal pTI-CAT promoter; Chen et al., 1996) . Cells were incubated for 40 h in the presence of DMEM containing 10% fetal bovine serum. Infected-transfected cells were harvested and cell lysates were prepared as described above. CAT assays were carried out at 378C for the indicated time periods in a total volume of 125 ml of 250 mM Tris-HCl (pH 7.8) buer containing 25 mg of butyryl coenzyme A, 0.25 mCi of [ 14 C]chloramphenicol (Moravek Biochemicals, Inc.) following the protocol supplied by Promega essentially as described (Gorman et al., 1982) . Acetylated [ 14 C]chloramphenicol derivatives separated by thin-layer chromatography were scraped and counted in a liquid scintillation counter. Each experiment was carried out in duplicates and was repeated at least once to ensure the reproducibility of the results.
Stable transfection of pRC-CMV13S or pRC-CMV12S into CV-1 cells
Experiments were carried out according to the protocol described (Kingston, 1991) with modi®cations. CV-1 cells were grown until 70% con¯uence and transfected with either pRC-CMV13S or pRC-CMV12S plasmid. Cells were harvested 45 h post-transfection by trypsinization, and plated at 1 : 10 dilution in a medium containing 400 mg/ ml of G418 in 60 mm culture plates. The cells were refed with fresh medium containing G418 every 4 or 5 days until all the untransfected cells died o. About ten G418-resistant colonies from each plate were pooled and the expression of E1A protein was veri®ed by Western blotting using a monoclonal antibody against E1A protein (data not shown). Pooled cells expressing E1A were ampli®ed as stably transfected cells.
Electrophoretic mobility shift assay (EMSA)
The 180-bp SmaI ± XbaI fragment containing the wild type or mutated CCAAT box motif(s) was dephosphorylated, and labeled with [g-32 P]-ATP by T4 polynucleotide kinase. In some experiments, synthetic double-stranded oligonucleotides (CCAAT box motifs of the cdc2: 5'-CATGGGCTCTGATTGGCTGCTTTG, HSP70: 5'-AGGCTCGGTGATTGGCTCAGAAGGATCTTCC, and tk: 5'-CCGGGCGCTGATTGGCCCCATGGC promoters and the E2F binding site of adenovirus E2A promoter: 5'-ATTTAAGTTTCGCGCGCCTTTAA, annealed to their respective complementary oligonucleotides) were used as probes. Nuclear extracts were prepared from cells cultured on monolayers as described (Zhao and Padmanabhan, 1988) .
EMSA was carried out as described (Chen et al., 1996) . Brie¯y, nuclear extracts were mixed with labeled probe in 20 ml of DNA-binding reaction buer containing 25 mM HEPES-KOH (pH 7.9), 5 mM KCl, 0.5 mM EDTA, 1 mg/ ml bovine serum albumin, 10% glycerol, 0.25 mM dithiothreitol and 0.1 mg/ml poly(dI-dC) and incubated at 378C for 30 min. The reaction was stopped by adding 2 ml of stop solution containing 50 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanole and 5% glycerol. The DNA-binding complexes were separated on a 4% polyacrylamide gel (19 : 1) in a buer containing 25 mM Tris, 192 mM glycine and 10 mM EDTA. The gel was dried and exposed to NEF-495 ®lm at 7708C.
DNA anity precipitation of CBF/cdc2
Double-stranded oligonucleotide containing the cdc2 CCAAT motif was biotin end-labeled using a kit and puri®ed by gel ®ltration on Sephadex G-25 column. The oligonucleotides (10 pmol) were bound to 200 ml (50% slurry) of streptavidin-agarose in 10 mM Tris-HCl, pH 8.0/ 1 mM EDTA (TE) for 1 h at 48C. The agarose beads were washed with TE and EMSA reaction buer to remove unbound oligonucleotides and ®nally resuspended in fresh EMSA reaction buer to make up a 50% slurry. The nuclear extracts from 293 cells (40 mg) in 100 ml of EMSA reaction buer was ®rst precleaned by incubation with 40 ml of streptavidin-agarose for 1 h at 48C. Then the supernatant extract was incubated with 40 ml of CCAAToligonucleotide bound streptavidin-agarose for 2 h at 48C. After washing the beads with EMSA reaction buer, the proteins-bound beads were analysed by SDS ± PAGE and Southwestern blotting using 32 P labeled-CCAAT/cdc2 as a probe. For competition experiments, the nuclear extracts were ®rst incubated with 106excess of unlabeled oligonucleotide and then subjected to biotin-labeled oligonucleotides as described above.
Southwestern analysis
The analysis was carried out as described (Chen et al., 1996) . Brie¯y, cells were fractionated into cytoplasmic and nuclear fractions and nuclear proteins were separated on a 6% or 8% SDS-polyacrylamide gel and transferred to a nitrocellulose membrane. After renaturing, the proteins on the membrane were probed with radiolabeled DNA fragment containing CCAAT-box binding sites. The membrane was then washed to remove unbound probe and exposed to NEF-495 ®lm at 7708C.
Northern blot analysis
Cells were grown to 70 ± 80% con¯uency in 100 mm dishes. Total RNA was extracted by RNA STAT-60 according to the manufacturer's instructions. RNA (20 mg) was fractionated on 1% agarose 6% formaldehyde gel and transferred onto nitrocellulose membrane. After heating the membrane in an oven at 808C for 2 h, the membrane was hybridized with 32 P-labeled probe using the QuickHyb hybridization solution. The probe used was a 3.0 kb fragment generated by NcoI digestion of pMT2-CBF (Lum et al., 1990) and labeled with 32 P-dCTP using Ready-to-Go DNA labeling beads. After washing, the membrane was subjected to autoradiography at 7708C.
